• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过多种技术与公共卫生伙伴关系加速新冠疫情高峰期间变异株的检测:来自印度尼西亚的案例研究

Accelerating Detection of Variants During COVID-19 Surges by Diverse Technological and Public Health Partnerships: A Case Study From Indonesia.

作者信息

Pradipta Ariel, Kumaheri Meutia Ayuputeri, Wahyudi Lilik Duwi, Susanto Anindya Pradipta, Agasi Harryyanto Ishaq, Shankar Anuraj H, Sudarmono Pratiwi

机构信息

Genomik Solidaritas Indonesia (GSI) Lab, Jakarta, Indonesia.

Indonesia Medical Education and Research Institute, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia.

出版信息

Front Genet. 2022 Jan 28;13:801332. doi: 10.3389/fgene.2022.801332. eCollection 2022.

DOI:10.3389/fgene.2022.801332
PMID:35154274
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8831855/
Abstract

Early detection of Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) variants and use of data for public health action requires a coordinated, rapid, and high throughput approach to whole genome sequencing (WGS). Currently, WGS output from many low- and middle-income countries (LMIC) has lagged. By fostering diverse partnerships and multiple sequencing technologies, Indonesia accelerated SARS-CoV-2 WGS uploads to GISAID from 1,210 in April 2021 to 5,791 in August 2021, an increase from 11 submissions per day between January to May, to 43 per day between June to August. Turn-around-time from specimen collection to submission decreased from 77 to 5 days, allowing for timely public health decisions. These changes were enabled by establishment of the National Genomic Surveillance Consortium, coordination between public and private sector laboratories with WGS capability, and diversification of sequencing platform technologies. Here we present how diversification on multiple levels enabled a rapid and significant increase of national WGS performance, with potentially valuable lessons for other LMICs.

摘要

早期发现严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变体并将数据用于公共卫生行动,需要一种协调、快速且高通量的全基因组测序(WGS)方法。目前,许多低收入和中等收入国家(LMIC)的WGS产出滞后。通过建立多样化的合作伙伴关系和采用多种测序技术,印度尼西亚将SARS-CoV-2的WGS数据上传至全球共享流感数据倡议组织(GISAID)的数量从2021年4月的1210份加速提升至2021年8月的5791份,从1月至5月期间每天提交11份增至6月至8月期间每天提交43份。从样本采集到提交的周转时间从77天缩短至5天,从而能够及时做出公共卫生决策.这些变化得益于国家基因组监测联盟(National Genomic Surveillance Consortium) 的成立、具备WGS能力 的公共部门和私营部门实验室之间 的协调以及测序平台技术 的多样化。在此,我们介绍多层次 的多样化如何实现国家WGS性能 的快速显著提升,这可能为其他低收入和中等收入国家提供宝贵经验。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ae8/8831855/d006a4be67d4/fgene-13-801332-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ae8/8831855/d006a4be67d4/fgene-13-801332-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ae8/8831855/d006a4be67d4/fgene-13-801332-g001.jpg

相似文献

1
Accelerating Detection of Variants During COVID-19 Surges by Diverse Technological and Public Health Partnerships: A Case Study From Indonesia.通过多种技术与公共卫生伙伴关系加速新冠疫情高峰期间变异株的检测:来自印度尼西亚的案例研究
Front Genet. 2022 Jan 28;13:801332. doi: 10.3389/fgene.2022.801332. eCollection 2022.
2
Sequencing Using a Two-Step Strategy Reveals High Genetic Diversity in the S Gene of SARS-CoV-2 after a High-Transmission Period in Tunis, Tunisia.两步策略测序揭示突尼斯高传播期后 SARS-CoV-2 S 基因的高遗传多样性。
Microbiol Spectr. 2021 Dec 22;9(3):e0063921. doi: 10.1128/Spectrum.00639-21. Epub 2021 Nov 10.
3
Analytical validity of nanopore sequencing for rapid SARS-CoV-2 genome analysis.纳米孔测序快速分析 SARS-CoV-2 基因组的分析有效性。
Nat Commun. 2020 Dec 9;11(1):6272. doi: 10.1038/s41467-020-20075-6.
4
Virus sequencing performance during the SARS-CoV-2 pandemic: a retrospective analysis of data from multiple rounds of external quality assessment in Austria.新冠疫情期间的病毒测序表现:奥地利多轮外部质量评估数据的回顾性分析
Front Mol Biosci. 2024 Feb 5;11:1327699. doi: 10.3389/fmolb.2024.1327699. eCollection 2024.
5
Whole-genome and targeted sequencing of drug-resistant Mycobacterium tuberculosis on the iSeq100 and MiSeq: A performance, ease-of-use, and cost evaluation.耐药结核分枝杆菌的全基因组和靶向测序在 iSeq100 和 MiSeq 上的性能、易用性和成本评估。
PLoS Med. 2019 Apr 30;16(4):e1002794. doi: 10.1371/journal.pmed.1002794. eCollection 2019 Apr.
6
Best approaches to drug-resistance surveillance at the country level.国家层面耐药性监测的最佳方法。
Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S40-S41. doi: 10.1016/j.ijmyco.2016.09.010. Epub 2016 Oct 21.
7
Genomic surveillance of SARS-CoV-2 in the Republic of Congo.刚果共和国新型冠状病毒的基因组监测。
Int J Infect Dis. 2021 Apr;105:735-738. doi: 10.1016/j.ijid.2021.03.036. Epub 2021 Mar 15.
8
Whole-genome sequencing of SARS-CoV-2 reveals the detection of G614 variant in Pakistan.全基因组测序揭示了 SARS-CoV-2 在巴基斯坦的 G614 变异株检测。
PLoS One. 2021 Mar 23;16(3):e0248371. doi: 10.1371/journal.pone.0248371. eCollection 2021.
9
Deepening of In Silico Evaluation of SARS-CoV-2 Detection RT-qPCR Assays in the Context of New Variants.在新变种背景下对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)检测逆转录定量聚合酶链反应(RT-qPCR)检测方法进行深入的计算机模拟评估
Genes (Basel). 2021 Apr 13;12(4):565. doi: 10.3390/genes12040565.
10
The role of whole genome sequencing in monitoring antimicrobial resistance: A biosafety and public health priority in the Arabian Peninsula.全基因组测序在监测抗生素耐药性中的作用:阿拉伯半岛的生物安全和公共卫生优先事项。
J Infect Public Health. 2018 Nov-Dec;11(6):784-787. doi: 10.1016/j.jiph.2018.08.001. Epub 2018 Aug 9.

引用本文的文献

1
Whole-Genome Sequencing and Mutation Analyses of SARS-CoV-2 Isolates from Indonesia.来自印度尼西亚的新型冠状病毒肺炎病毒分离株的全基因组测序与突变分析
Pathogens. 2024 Mar 25;13(4):279. doi: 10.3390/pathogens13040279.
2
Full-genome sequencing and mutation analysis of SARS-CoV-2 isolated from Makassar, South Sulawesi, Indonesia.从印度尼西亚南苏拉威西省望加锡分离的 SARS-CoV-2 的全基因组测序和突变分析。
PeerJ. 2022 Jun 10;10:e13522. doi: 10.7717/peerj.13522. eCollection 2022.

本文引用的文献

1
Comparative analysis of 7 short-read sequencing platforms using the Korean Reference Genome: MGI and Illumina sequencing benchmark for whole-genome sequencing.基于韩国参考基因组的 7 种短读测序平台的比较分析:MGI 和 Illumina 测序在全基因组测序中的基准测试。
Gigascience. 2021 Mar 12;10(3). doi: 10.1093/gigascience/giab014.
2
Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study.202012/1 感染关注的 SARS-CoV-2 变异株的患者的死亡率风险:匹配队列研究。
BMJ. 2021 Mar 9;372:n579. doi: 10.1136/bmj.n579.
3
COVID-19 in early 2021: current status and looking forward.
2021 年初的 COVID-19:现状与展望。
Signal Transduct Target Ther. 2021 Mar 8;6(1):114. doi: 10.1038/s41392-021-00527-1.
4
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England.在英格兰,估计 SARS-CoV-2 谱系 B.1.1.7 的传染性和影响。
Science. 2021 Apr 9;372(6538). doi: 10.1126/science.abg3055. Epub 2021 Mar 3.
5
SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity.SARS-CoV-2 的 D614G 刺突突变提高了与 ACE2 的结合亲和力,从而增加了进入效率。
Nat Commun. 2021 Feb 8;12(1):848. doi: 10.1038/s41467-021-21118-2.
6
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.在年轻和老年成年人中进行的一次单盲、随机、对照、2/3 期试验中,观察 ChAdOx1 nCoV-19 疫苗在初免-加强免疫方案中的安全性和免疫原性(COV002)。
Lancet. 2021 Dec 19;396(10267):1979-1993. doi: 10.1016/S0140-6736(20)32466-1. Epub 2020 Nov 19.
7
Optimized use of Oxford Nanopore flowcells for hybrid assemblies.优化 Oxford Nanopore 流动池在混合组装中的使用。
Microb Genom. 2020 Nov;6(11). doi: 10.1099/mgen.0.000453.
8
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus.追踪 SARS-CoV-2 刺突蛋白的变化:D614G 增加 COVID-19 病毒感染力的证据。
Cell. 2020 Aug 20;182(4):812-827.e19. doi: 10.1016/j.cell.2020.06.043. Epub 2020 Jul 3.
9
Early transmission patterns of coronavirus disease 2019 (COVID-19) in travellers from Wuhan to Thailand, January 2020.2020 年 1 月,武汉旅行者感染 2019 年冠状病毒病(COVID-19)的早期传播模式。
Euro Surveill. 2020 Feb;25(8). doi: 10.2807/1560-7917.ES.2020.25.8.2000097.
10
Bioinformatics of nanopore sequencing.纳米孔测序的生物信息学。
J Hum Genet. 2020 Jan;65(1):61-67. doi: 10.1038/s10038-019-0659-4. Epub 2019 Aug 26.